California Cancer Reporting System Standards, Volume III

 

Eureka Edits

This edit has been retired.

IF419 CS SSF 21, SurgRad Seq, SurSys Seq, Breast (CS)

 

Edit Sets

Eureka Hospital Transmit

Eureka Tumor Level

Eureka Admission Level

 

Fields

Behavior Code ICD-0-3 [NAACCR #523]

CS Site Specific Factor 21 [NAACCR #2875]

CS Site Specific Factor 25 [NAACCR #2879]

Histologic Type ICD-0-3 [NAACCR #522]

Primary Site [NAACCR #400]

RX Summ—Surg/Rad/Seq [NAACCR #1380]

RX Summ—Systemic/Sur Seq [NAACCR #1639]

 

Message

If CS Site Specific Factor 21 = [value], either RX Summ—Surg/Rad/Seq [value] or RX Summ—Systemic/Sur Seq [value] must = 2 or 4.

If CS Site Specific Factor 21 = [value], RX Summ—Surg/Rad/Seq [value] and RX Summ—Systemic/Sur Seq [value] cannot = 2 or 4.

 

Specification

This edit applies only to cases coded using the Breast schema. If SSF 21 (Response to Neoadjuvant Therapy) indicates the patient received neoadjuvant therapy, then either Systemic/Surgery Sequence or Radiation/Surgery Sequence must indicate that systemic or radiation treatment occurred before surgery. If SSF 21 indicates patient recieved no neoadjuvant therapy, then both Systemic/Surgery Sequence and Radiation/Surgery Sequence must indicate no treatment given before surgery.

This edit first determines the correct CS schema by doing a function call to the CS Dynamic Link Library (dll).  The function call passes Primary Site, Histologic Type ICD-O-3, and CS Site-Specific Factor25 (schema discriminator) to the dll and the CS schema name is returned.

 

This edit is skipped if any of the following conditions are true:

  1. CS Site-Specific Factor21 is blank or 988

  2. RX Summ--Systemic/Sur Seq is blank

  3. RX Summ--Surg/Rad Seq is blank

  4. Behavior Code ICD-O-3 = 0 (benign) or 1 (borderline)

  5. CS schema is invalid

 

If CS schema is Breast:

If CS Site-Specific Factor21 = 010, 020, or 030 (received neoadjuvant therapy), then at least one of the following must be true:

RX Summ--Systemic/Sur Seq must = 2 (systemic therapy before surgery) or 4 (systemic therapy both before and after surgery)

RX Summ--Surg/Rad Seq must = 2 (radiation before surgery) or 4 (radiation both before and after surgery)

 

If CS Site-Specific Factor21 = 987 (neoadjuvant therapy not given), then both of the following must be true:

RX Summ--Systemic/Sur Seq must not = 2 or 4

RX Summ--Surg/Rad Seq must not = 2  or 4

 

 

Historical Changes

In the SEER*Edits software, the title of this edit is: IF372

7/27/11 New edit for NAACCR 12.1.A.
May 2013 Edit Deleted